Men, baby boomers, and postgraduate-degree holders were among those most likely to say they wouldn’t choose medication over ...

Speakers from across the care continuum will discuss legislative updates, glucagon-like peptide-1 (GLP-1) use for weight management, and more at this year’s AMCP Nexus.

The novel GLP-1 receptor agonists will likely reduce the need for CABG and improve surgical outcomes, several argue.

Eli Lilly intensifies its legal efforts against compounding pharmacies producing copycat versions of its weight-loss drugs, ...

Skye Bioscience (NASDAQ: SKYE) is a micro-cap pharmaceutical company that is striving to become the next big thing in the weight loss drug space.

On October 3, 2024, the US Food and Drug Administration (FDA) revised its shortage categorization of tirzepatide, a glucagon-like peptide 1 ...

The surge in popularity of drugs like Ozempic, driven in part by its weight loss benefits, is contributing to a record-high ...

In this randomized controlled trial, in patients with both moderate-severe obstructive sleep apnea (OSA) and obesity, it was ...

Prime Therapeutics LLC (Prime) continues to position itself as a leader in the pharmacy solutions industry by presenting 10 research studies at the 2024 Academy of Managed Care Pharmacy (AMCP) Nexus ...

The pharmaceutical industry has seen a tremendous surge in the development of weight loss drugs, particularly GLP-1 receptor ...

Kathy Bates has made an extremely candid Ozempic admission after revealing the unbelievable amount of weight she's lost. The ...

Just like when you find a glitzy resort in your dream destination, your first question about weight loss drugs might be, how ...